‘An excellent scientist and leader’ Heard succeeds the Crick’s founding Director and Chief Executive, Sir Paul Nurse, who will continue to maintain a ...

Receiving support from nurse navigators — even just to talk — allowed Ginger to think more positively during breast cancer. Diagnosed in 2011 with breast ...

The number of cancer cases caused by smoking in the UK has reached an all-time high of 160 cases every day, new analysis from Cancer Research UK shows.  ...

Cancer is not a simple disease. A person’s risk of cancer can be affected by many things. These are known as risk factors and include things we can’t ...

Sydney Stern has undergone six surgeries for TGCT, or tenosynovial giant cell tumors. “So, we’ll say five too many, maybe,” she told CURE®.Stern, director ...

There are not many patients with tenosynovial giant cell tumors, or TGCTs, with one expert telling CURE® that “about one in 1 million patients” will be ...

Tenosynovial giant cell tumors, or TGCTs, are non-malignant, but have plenty in common with cancer in terms of impacting patients’ quality of life, as ...

From left: DR. EDWARD A. FABER JR., and GINA YOUNG, B.S.N., RN PHOTOS BY LANCE ADKINSFor the past 10 years, B.S.N., RN, has been associated with my program ...

Bispecific antibodies can be administered either intravenously or subcutaneously, which is the more convenient option, an expert told CURE®. Bispecific ...

As a patient with prostate cancer, I’ve grown used to hearing my doctor say, “We’ll just have to watch and wait.”I’ll gladly admit the overwhelming feeling ...

Sydney Stern understands the importance of a multidisciplinary care team when treating tenosynovial giant cell tumors, or TGCTs. Stern, Director of Giant ...

Patients with TGCTs, or tenosynovial giant cell tumors, often have to deal with pain and discomfort as a result of the condition, a rare benign tumor that ...